AYER CAPITAL MANAGEMENT, LP
230 CALIFORNIA, SUITE 600, SAN FRANCISCO, California, 94111, (415) 874-4800
Report Date: 03/31/2013
Position Statistics:
| Total Positions | 27 |
| New Positions | 4 |
| Increased Positions | 4 |
| Decreased Positions | 22 |
| Positions with Activity | 26 |
| Sold Out Positions | 5 |
| Total Mkt Value (in $ millions) |
115 |
Sector Weighting
| Basic Materials | |
| Capital Goods | |
| Conglomerates | |
| Consumer Cyclical | |
| Consumer/Non-Cyclical | |
| Energy | |
| Financial | |
| Healthcare | 90.78% |
| Services | 9.22% |
| Technology | |
| Transportation | |
| Utilities |
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.
27 Positions as of 03/31/2013
| Company | Class | Value of Shares ($1,000s) |
Change in Value ($1,000s) | Change (%) | Shares Held |
|---|---|---|---|---|---|
| ATRICURE INC | COM | -1,174 | Sold Out | 0 | |
| HEALTH MGMT ASSOC INC NEW | CL A | -2,061 | Sold Out | 0 | |
| NOVAVAX INC | COM | -5,574 | Sold Out | 0 | |
| OMEROS CORP | COM | -872 | Sold Out | 0 | |
| PALATIN TECHNOLOGIES INC | COM PAR $ .01 | -717 | Sold Out | 0 | |
| ORTHOFIX INTL N V | COM | 162 | 162 | New | 6,100 |
| BIOLINERX LTD | SPONSORED ADR | 497 | -1,573 | (76) | 277,604 |
| CYCLACEL PHARMACEUTICALS INC | COM NEW | 671 | New | 220,593 | |
| THRESHOLD PHARMACEUTICAL INC | COM NEW | 815 | -3,601 | (81.55) | 146,321 |
| PEREGRINE PHARMACEUTICALS INC | COM NEW | 1,078 | -7,302 | (87.14) | 699,935 |
| CHEMOCENTRYX INC | COM | 1,753 | -3,639 | (67.49) | 128,838 |
| GILEAD SCIENCES INC | COM | 1,758 | 1,758 | New | 31,226 |
| INSMED INC | COM PAR $.01 | 3,028 | -13,146 | (81.28) | 277,781 |
| ACCURAY INC | COM | 3,067 | 3,067 | New | 583,044 |
| ARIAD PHARMACEUTICALS INC | COM | 4,869 | -4,594 | (48.55) | 292,106 |
| EXPRESS SCRIPTS HLDG CO | COM | 4,927 | -4,119 | (45.53) | 79,629 |
| MCKESSON CORP | COM | 5,524 | -6,288 | (53.23) | 47,259 |
| CVS CAREMARK CORPORATION | COM | 5,638 | 5,638 | New | 94,844 |
| UNIVERSAL HLTH SVCS INC | CL B | 5,658 | -1,496 | (20.92) | 84,392 |
| TEVA PHARMACEUTICAL INDS LTD | ADR | 6,062 | -13,100 | (68.36) | 150,690 |
Latest News Headlines
Goldman Sachs Chief Confident Euro will Survive - Report 10:24AM ET - Dow Jones Business News
Google CEO Schmidt Defends Tax Affairs amid Fresh Claims - Newspapers 10:20AM ET - Dow Jones Business News
GRAVITY Reports First Quarter of 2013 Results 9:00AM ET - GlobeNewswire
MARKET SNAPSHOT: Stock Rally's Breadth Is A Sign Of Strength, Froth 8:05AM ET - Dow Jones Business News
Shell Had Lobbied against Tighter Regulation - Report 7:05AM ET - Dow Jones Business News
View All